News

Indian pharmaceutical companies must embrace innovation and adopt technology if they are to stay competitive at both domestic and global level, experts say.

The NHS Commissioning Board has launched a library of NHS-reviewed health apps to help people manage their health.

Orion Corp of Finland and Hungary’s Gedeon Richter have entered into “a comprehensive and long-term collaboration” looking at new chemical entities for cognitive disorders.

Merck & Co’s stock enjoyed a boost yesterday after it revealed it has been given permission to continue a late-stage trial of its cholesterol buster Vytorin.

Interpol and 29 of the world’s largest pharmaceutical companies have launched another initiative to combat the spread of counterfeit drugs.

Eyebrows have been raised after Astellas Pharma decided to end its collaboration with Ambit Biosciences Corp to develop the latter’s acute myeloid leukaemia treatment quizartinib.

Ministers have announced a second wave of funding from the Biomedical Catalyst fund, which will provide 51 biomedical businesses with a total of £47.2 million to help them bridge the R&D “valley of death.”

Catalent Pharma Solutions is opening a gateway to China for its clinical-trial supplies business through a joint venture with locally based contract research organisation ShangPharma Corporation.

Incentives to encourage the pharmaceutical industry to develop new antibiotics must be put in place, and fast, or in just 20 years minor operations could be fatal, chief medical officer Dame Sally Davies has warned.

The government has introduced revised regulations to parliament to clarify that clinical commissioners will not be forced to create competitive markets for National Health services against their will.

The provision of pharmaceutical care in Greece is now at breaking point, and the blame lies with the Health Ministry, according to the national pharmaceutical industry association.

A lack of awareness of the symptoms of ovarian cancer among both women and GPs is leading to more patients being diagnosed in the advanced stages of the disease, findings from a Roche-sponsored study suggest.

Registration has now opened for a site-metrics registry that represents the first fruit of an initiative by academic research centres in the US to streamline clinical-research processes by working together online.

US biopharmaceutical companies are using biological processes to develop 907 drugs and vaccines targeting more than 100 diseases, according to new industry data.

Vifor Pharma has completed its submissions in the major markets for PA21 by filing the new phosphate binder with Swiss regulators.